The Worst Mistake Moderna Investors Can Make Right Now

The Worst Mistake Moderna Investors Can Make Right Now

In late 2018, Moderna (NASDAQ: MRNA) went public in the largest biotech IPO in history. Now that its coronavirus vaccine has received Emergency Use Authorization, some investors might think there is limited upside left in the stock. Working with the National Institute of Allergy and Infectious Diseases, the company delivered a vaccine just 42 days after the genome sequence of the novel coronavirus was made public.